MTAP-Null Tumors: A Comprehensive Review on Synthetic Vulnerabilities and Therapeutic Strategies

Bavani Subramaniam, Wai Chin Chong, Aylar Babaei, Miriam Bornhorst, Chunchao Zhang, Roger Packer, Javad Nazarian, Edward V Prochownik · 2025

Read MTAP-Null Tumors: A Comprehensive Review on Synthetic Vulnerabilities and Therapeutic Strategies by Bavani Subramaniam, Wai Chin Chong, Aylar Babaei, Miriam Bornhorst, Chunchao Zhang, Roger Packer, Javad Nazarian, Edward V Prochownik (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12732168.txt.

Description

Bavani Subramaniam and seven co-authors review cancers that have lost a gene called MTAP, in a 2025 survey. The loss rides along with a common deletion that also removes two famous tumor suppressor genes. It strikes about fifteen percent of all cancers. The lost gene runs a salvage path for a key building block, so its loss leaves tumor cells with weak spots that drugs might exploit.

The review maps how often the loss occurs by cancer type and how it reshapes cell chemistry and the immune setting. It sorts past drug tries, both before and after gene-screen tools arrived. Current trials mostly aim at one paired drug axis, with mixed results so far. The authors urge smart drug pairings built on that axis. They frame the review as a guide for the next round of trials.

Catalog record

CREATORBavani Subramaniam, Wai Chin Chong, Aylar Babaei, Miriam Bornhorst, Chunchao Zhang, Roger Packer, Javad Nazarian, Edward V Prochownik
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE65 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12732168

Browse the full library · About the Tower of Babel